Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis"

Affiliations

• ¹ Second Department of Neurology, "Attikon" Hospital, School of Medicine, National and Kapodistrian University of Athens, Iras 39, Gerakas Attikis, Athens, 15344, Greece. tsivgoulisgiorg@yahoo.gr.
• ² Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA. tsivgoulisgiorg@yahoo.gr.
• ³ Second Department of Neurology, "Attikon" Hospital, School of Medicine, National and Kapodistrian University of Athens, Iras 39, Gerakas Attikis, Athens, 15344, Greece.
• ⁴ Department of Neurology, School of Medicine, University of Ioannina, Ioannina, Greece.
• ⁵ Department of Neurology, University Hospital of Larissa, University of Thessaly, Larissa, Greece.
• ⁶ Department of Neurology, Alexandroupolis University Hospital, Democritus University of Thrace, Alexandroupolis, Greece.
• ⁷ Second Department of Neurology, "AHEPA" University Hospital, Aristotelion University of Thessaloniki, Thessaloniki, Macedonia, Greece.
• ⁸ Department of Neurology, University of Patras Medical School, Patras, Greece.
• ⁹ First Department of Neurology, "Eginition" Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.